AnaptysBio (ANAB)
(Real Time Quote from BATS)
$38.69 USD
+1.16 (3.09%)
Updated Sep 20, 2024 03:36 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
AnaptysBio, Inc. (ANAB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$51.45 | $80.00 | $23.00 | 37.09% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for AnaptysBio, Inc. comes to $51.45. The forecasts range from a low of $23.00 to a high of $80.00. The average price target represents an increase of 37.09% from the last closing price of $37.53.
Analyst Price Targets (11)
Broker Rating
AnaptysBio, Inc. currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, 10 are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.33 | 1.55 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | Truist Securities | Joon Lee | Hold | Hold |
8/5/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
7/22/2024 | H.C. Wainwright & Co. | Emily Bodnar | Not Available | Strong Buy |
7/17/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
5/1/2024 | UBS | Eliana Merle | Hold | Hold |
4/16/2024 | SVB Securities | David Risinger | Not Available | Strong Buy |
4/11/2024 | Wells Fargo Securities | Derek C Archila | Not Available | Strong Buy |
4/1/2024 | Cowen & Co. | Joseph Thome | Strong Buy | Strong Buy |
2/26/2024 | BTIG | Julian Harrison | Not Available | Strong Buy |
2/21/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/12/2024 | Guggenheim Securities | Yatin Suneja | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 12 |
Average Target Price | $51.45 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 253 |
Current Quarter EPS Est: | -1.72 |
ANAB FAQs
AnaptysBio, Inc. (ANAB) currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for AnaptysBio, Inc. (ANAB) is $51.45. The current on short-term price targets is based on 8 reports.
The forecasts for AnaptysBio, Inc. (ANAB) range from a low of $23 to a high of $80. The average price target represents a increase of $37.09 from the last closing price of $37.53.
The current UPSIDE for AnaptysBio, Inc. (ANAB) is 37.09%
Based on short-term price targets offered by 11 analysts, the average price target for AnaptysBio, Inc. comes to $51.45. The forecasts range from a low of $23.00 to a high of $80.00. The average price target represents an increase of 37.09% from the last closing price of $37.53.